Pirozhkov A, Dozmorov I, Petrov R
Department of Immunology, Schemyakin and Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, Russia.
Bone Marrow Transplant. 1995 Nov;16(5):683-93.
The growth of hemopoietic stem cells of C57BL/6 mice was explored in syngeneic and semi-syngeneic foci of heterotopic hemopoiesis, formed under the kidney capsule of (CBA x C57BL/6)F1 recipients with and without prior treatment with cyclophosphamide or fractionated irradiation, which is known to abrogate hybrid resistance and NK cell activity. Our results show that the suppression of the growth of parent stem cells in semi-syngeneic F1-recipients is due to NK cell participation. However, no inhibition was found in the growth of identical cells in the foci of syngeneic hemopoietic stroma in the same recipients, despite the presence of NK cell activity. The experimental model used shows clearly that hybrid resistance is the result of the joint involvement of NK cells and the semi-syngeneic stroma.
在(CBA×C57BL/6)F1受体小鼠肾被膜下形成的同基因和半同基因异位造血灶中,研究了C57BL/6小鼠造血干细胞的生长情况。这些受体小鼠在有或没有预先用环磷酰胺或分次照射处理的情况下,已知环磷酰胺或分次照射可消除杂种抗性和NK细胞活性。我们的结果表明,半同基因F1受体中亲代干细胞生长的抑制是由于NK细胞的参与。然而,尽管存在NK细胞活性,但在相同受体的同基因造血基质灶中相同细胞的生长未发现受到抑制。所使用的实验模型清楚地表明,杂种抗性是NK细胞和半同基因基质共同参与的结果。